254 related articles for article (PubMed ID: 36055392)
41. Vitamin C-Induced Epigenetic Modifications in Donor NSCs Establish Midbrain Marker Expressions Critical for Cell-Based Therapy in Parkinson's Disease.
Wulansari N; Kim EH; Sulistio YA; Rhee YH; Song JJ; Lee SH
Stem Cell Reports; 2017 Oct; 9(4):1192-1206. PubMed ID: 28943252
[TBL] [Abstract][Full Text] [Related]
42. A novel two-factor monosynaptic TRIO tracing method for assessment of circuit integration of hESC-derived dopamine transplants.
Aldrin-Kirk P; Åkerblom M; Cardoso T; Nolbrant S; Adler AF; Liu X; Heuer A; Davidsson M; Parmar M; Björklund T
Stem Cell Reports; 2022 Jan; 17(1):159-172. PubMed ID: 34971563
[TBL] [Abstract][Full Text] [Related]
43. Single-cell transcriptomics reveals the cell fate transitions of human dopaminergic progenitors derived from hESCs.
Liang L; Tian Y; Feng L; Wang C; Feng G; Stacey GN; Shyh-Chang N; Wu J; Hu B; Li W; Hao J; Wang L; Wang Y
Stem Cell Res Ther; 2022 Aug; 13(1):412. PubMed ID: 35964138
[TBL] [Abstract][Full Text] [Related]
44. Single-cell transcriptional and functional analysis of dopaminergic neurons in organoid-like cultures derived from human fetal midbrain.
Birtele M; Storm P; Sharma Y; Kajtez J; Wahlestedt JN; Sozzi E; Nilsson F; Stott S; He XL; Mattsson B; Ottosson DR; Barker RA; Fiorenzano A; Parmar M
Development; 2022 Dec; 149(23):. PubMed ID: 36305490
[TBL] [Abstract][Full Text] [Related]
45. Human Stem Cell-Derived Neurons Repair Circuits and Restore Neural Function.
Xiong M; Tao Y; Gao Q; Feng B; Yan W; Zhou Y; Kotsonis TA; Yuan T; You Z; Wu Z; Xi J; Haberman A; Graham J; Block J; Zhou W; Chen Y; Zhang SC
Cell Stem Cell; 2021 Jan; 28(1):112-126.e6. PubMed ID: 32966778
[TBL] [Abstract][Full Text] [Related]
46. Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease: Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment.
Kim SW; Woo HJ; Kim EH; Kim HS; Suh HN; Kim SH; Song JJ; Wulansari N; Kang M; Choi SY; Choi SJ; Jang WH; Lee J; Kim KH; Lee W; Kim SH; Yang J; Kyung J; Lee HS; Park SM; Chang MY; Lee SH
Prog Neurobiol; 2021 Sep; 204():102086. PubMed ID: 34052305
[TBL] [Abstract][Full Text] [Related]
47. Strategies for bringing stem cell-derived dopamine neurons to the clinic: A European approach (STEM-PD).
Kirkeby A; Parmar M; Barker RA
Prog Brain Res; 2017; 230():165-190. PubMed ID: 28552228
[TBL] [Abstract][Full Text] [Related]
48. Single-Cell Transcriptomics and In Vitro Lineage Tracing Reveals Differential Susceptibility of Human iPSC-Derived Midbrain Dopaminergic Neurons in a Cellular Model of Parkinson's Disease.
Cardo LF; Monzón-Sandoval J; Li Z; Webber C; Li M
Cells; 2023 Dec; 12(24):. PubMed ID: 38132179
[TBL] [Abstract][Full Text] [Related]
49. Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy.
Cooper O; Parmar M; Isacson O
Prog Brain Res; 2012; 200():265-76. PubMed ID: 23195423
[TBL] [Abstract][Full Text] [Related]
50. Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation.
Doi D; Samata B; Katsukawa M; Kikuchi T; Morizane A; Ono Y; Sekiguchi K; Nakagawa M; Parmar M; Takahashi J
Stem Cell Reports; 2014 Mar; 2(3):337-50. PubMed ID: 24672756
[TBL] [Abstract][Full Text] [Related]
51. Immature Midbrain Dopaminergic Neurons Derived from Floor-Plate Method Improve Cell Transplantation Therapy Efficacy for Parkinson's Disease.
Qiu L; Liao MC; Chen AK; Wei S; Xie S; Reuveny S; Zhou ZD; Hunziker W; Tan EK; Oh SKW; Zeng L
Stem Cells Transl Med; 2017 Sep; 6(9):1803-1814. PubMed ID: 28650520
[TBL] [Abstract][Full Text] [Related]
52. Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons.
Sheta R; Teixeira M; Idi W; Pierre M; de Rus Jacquet A; Emond V; Zorca CE; Vanderperre B; Durcan TM; Fon EA; Calon F; Chahine M; Oueslati A
Sci Rep; 2022 Oct; 12(1):17176. PubMed ID: 36229560
[TBL] [Abstract][Full Text] [Related]
53. Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1.
Samata B; Doi D; Nishimura K; Kikuchi T; Watanabe A; Sakamoto Y; Kakuta J; Ono Y; Takahashi J
Nat Commun; 2016 Oct; 7():13097. PubMed ID: 27739432
[TBL] [Abstract][Full Text] [Related]
54. Generation of functional dopaminergic neurons from human spermatogonial stem cells to rescue parkinsonian phenotypes.
Yang H; Hao D; Liu C; Huang D; Chen B; Fan H; Liu C; Zhang L; Zhang Q; An J; Zhao J
Stem Cell Res Ther; 2019 Jun; 10(1):195. PubMed ID: 31248447
[TBL] [Abstract][Full Text] [Related]
55. Wnt/β-catenin signaling is required to rescue midbrain dopaminergic progenitors and promote neurorepair in ageing mouse model of Parkinson's disease.
L'Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Serapide MF; Pluchino S; Marchetti B
Stem Cells; 2014 Aug; 32(8):2147-63. PubMed ID: 24648001
[TBL] [Abstract][Full Text] [Related]
56. Idiopathic Parkinson's disease patient-derived induced pluripotent stem cells function as midbrain dopaminergic neurons in rodent brains.
Kikuchi T; Morizane A; Doi D; Okita K; Nakagawa M; Yamakado H; Inoue H; Takahashi R; Takahashi J
J Neurosci Res; 2017 Sep; 95(9):1829-1837. PubMed ID: 28233934
[TBL] [Abstract][Full Text] [Related]
57. [Cell replacement therapy for Parkinson's disease using iPS cells].
Takahashi J
Rinsho Shinkeigaku; 2013; 53(11):1009-12. PubMed ID: 24291862
[TBL] [Abstract][Full Text] [Related]
58. Survival, differentiation, and connectivity of ventral mesencephalic dopamine neurons following transplantation.
Thompson L; Björklund A
Prog Brain Res; 2012; 200():61-95. PubMed ID: 23195415
[TBL] [Abstract][Full Text] [Related]
59. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
[TBL] [Abstract][Full Text] [Related]
60. Molecular Features of Parkinson's Disease in Patient-Derived Midbrain Dopaminergic Neurons.
Ren Y; Jiang H; Pu J; Li L; Wu J; Yan Y; Zhao G; Guttuso TJ; Zhang B; Feng J
Mov Disord; 2022 Jan; 37(1):70-79. PubMed ID: 34564901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
